Note: Ingredients listed on restricted chemical lists
EC/CAS
215-137-3/1305-62-0
Name of the chemical
Calcium dihydroxide
Concentration
>=20.0-<30.0%
EC/CAS
232-384-2/8012-95-1
Name of the chemical
PO, Paraffin-oils
Concentration
>=20.0-<30.0%
General Information
Version
8.0
Revision date
2022-10-04
Product name
MOLYKOTE P-74 Paste
1.2.1 Relevant identified uses
Lubricants and lubricant additives
Manufacturer Name
DuPont Specialty Products GmbH & Co. KG
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
DuPont Specialty Products GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion-EU@dupont.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H315, H318, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
DANGER
Hazard statements
H315 Causes skin irritation. H318 Causes serious eye damage. H335 May cause respiratory irritation.
Precautionary statements
P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ eye protection/ face protection. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a + P312 POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ P310 doctor. P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
Contains
Calcium hydroxide
2.3 Other hazards
Endocrine disrupting properties (human health): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine disrupting properties (environment): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008: Skin irritation - Category 2 - H315 ® ™ Trademark of affiliates of DuPont de Nemours, Inc. Serious eye damage - Category 1 - H318 Specific target organ toxicity - single exposure - Category 3 - H335 For the full text of the H-Statements mentioned in this Section, see Section 16.
